Mechanisms for Mitoprotection and Amelioration of Acute Kidney Injury Risk

Center for Precision Medicine, Long School of Medicine, University of Texas Health San Antonio, and Division of Nephrology, Department of Medicine, University of Texas Health San Antonio, San Antonio, Texas Correspondence: Dr. Kumar Sharma, email: [email protected] See related article, "Genome-Wide CRISPR Screen Identifies Phospholipid Scramblase 3 as the Biological Target of Mitoprotective Drug SS-31," on pages 681–695.